↓ Skip to main content

Results of a phase I/II clinical trial: standardized, non-xenogenic, cultivated limbal stem cell transplantation

Overview of attention for article published in Journal of Translational Medicine, January 2014
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
89 Dimensions

Readers on

mendeley
103 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Results of a phase I/II clinical trial: standardized, non-xenogenic, cultivated limbal stem cell transplantation
Published in
Journal of Translational Medicine, January 2014
DOI 10.1186/1479-5876-12-58
Pubmed ID
Authors

Nadia Zakaria, Tine Possemiers, Sorcha Dhubhghaill, Inge Leysen, Jos Rozema, Carina Koppen, Jean-Pierre Timmermans, Zwi Berneman, Marie-Jose Tassignon

Abstract

To determine if a standardized, non-xenogenic, reduced manipulation cultivation and surgical transplantation of limbal stem cell grafts is a safe and effective treatment option for patients with total and partial limbal stem cell deficiency.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 103 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 15%
Student > Ph. D. Student 14 14%
Other 11 11%
Student > Bachelor 10 10%
Student > Master 10 10%
Other 17 17%
Unknown 26 25%
Readers by discipline Count As %
Medicine and Dentistry 33 32%
Agricultural and Biological Sciences 13 13%
Biochemistry, Genetics and Molecular Biology 9 9%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Engineering 3 3%
Other 8 8%
Unknown 33 32%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 March 2014.
All research outputs
#17,268,117
of 21,364,317 outputs
Outputs from Journal of Translational Medicine
#2,802
of 3,689 outputs
Outputs of similar age
#145,557
of 201,831 outputs
Outputs of similar age from Journal of Translational Medicine
#1
of 1 outputs
Altmetric has tracked 21,364,317 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,689 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.0. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 201,831 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them